First AD

Second AD

Early treatment of new onset multiple sclerosis (MS) with interferon Î²-1b therapy leads to clinical benefits. Several risk factors may help identify epilepsy patients who may be at higher risk for psychosis due to their antiepileptic drug treatment. Topiramate is an appropriate treatment for epilepsy patients with comorbid migraine.

Epilepsy

 epilepsy clinical focus page provides information, podcasts, videos, and news about the latest FDA actions, clinical guideline updates, study and clinical trial findings, and interviews with physicians related to epilepsy and related epileptic conditions, including Lennox-Gastaut syndrome, Dravet syndrome, tuberous sclerosis complex, focal seizures, nonmotor seizures, and more.

Headache and Migraine

 headache and migraine clinical focus page offers information, podcasts, videos, and news and interviews with physicians related to the care of patients with headache disorders such as chronic and episodic migraine, cluster headache, tension-type headache, and more. The page includes updates on the latest FDA actions, clinical guidelines, and study and clinical trial findings.

Multiple Sclerosis

 multiple sclerosis (MS) clinical focus page offers information, podcasts, videos, and news about the latest study and clinical trial findings, FDA actions, clinical guideline updates, and expert interviews related to the care and management of patients with MS, including relapsing MS and progressive MS, as well as related disorders such as neuromyelitis optica spectrum disorder.

New research covers treating MS early, identifying those at risk for AED-induced psychosis, & selecting a drug for epilepsy patients with migraines.

Neuro News Roundup: Treating MS & Epilepsy